Close Menu

NEW YORK – The Press On Fund has donated $100,000 to the Leukemia & Lymphoma Society to advance the LLS PedAl pediatric precision oncology master trial.

The goal of LLS PedAI is to study the efficacy and safety of multiple precision oncology drugs at once for children with relapsed acute leukemia. The trial, which will involve as many as 200 sites globally, will match children to a targeted treatment based on the molecular alterations driving their cancers.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.